EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RLYB: Rallybio Corporaton

24 Oct 25 15:59
LAST:

0.6112

CHANGE:
 0.01		OPEN:
0.5938		HIGH:
0.6250		ASK:
0.0000		VOLUME:
192.9K
CHG(%):
1.67		PREV:
0.6000		LOW:
0.5801		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Oct 250.59000.62500.58010.6100194.7K
23 Oct 250.56000.60970.54000.6000388.8K
22 Oct 250.57600.57600.55050.5609104.6K
21 Oct 250.54400.56860.54250.5600160.5K
20 Oct 250.53600.56870.53510.5519100.8K
17 Oct 250.53670.55040.52900.5351102.5K
16 Oct 250.53340.56910.51860.5539210.9K
15 Oct 250.54000.56000.52090.5358211.8K
14 Oct 250.51230.54000.49600.5348184.6K
13 Oct 250.50100.53310.49000.5281202.3K

COMPANY PROFILE

Name:Rallybio Corporaton
About:Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. It entered into a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases; and collaboration agreement with Johnson & Johnson to provide pregnant individuals therapeutic solutions at risk of fetal and neonatal alloimmune thrombocytopenia. The company was founded in 2018 and is headquartered in New Haven, Connecticut.
Sector:Healthcare
Industry:Biotechnology
Address:234 Church Street, New Haven, CT, United States, 06510
Website:https://www.rallybio.com
CUSIP:75120L100
CIK:0001739410
ISIN:US75120L1008
FIGI:BBG011PFKF54

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.586.0%
MA10:0.569.7%
MA20:0.5511.2%
MA50:0.576.7%
MA100:0.5022.8%
MA200:0.5315.1%
STO9:83.37 
STO14:86.85 
RSI14:57.86
MTM14:0.05
ROC14:0.09 
ATR:0.04 
Week High:0.632.3%
Week Low:0.5315.5%
Month High:0.632.3%
Month Low:0.4815.1%
Year High:1.24102.9%
Year Low:0.22177.7%
Volatility:26.40